8.25
+0.10
+(1.23%)
At close: 3:38:47 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 3 | 3 |
| Avg. Estimate | 0 | 0 | -0.01 | -0.01 |
| Low Estimate | 0 | 0 | -0.01 | -0.01 |
| High Estimate | 0 | 0 | -0.01 | -0.01 |
| Year Ago EPS | -- | -- | -0.01 | -0.01 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 3 | 3 |
| Avg. Estimate | -- | -- | 5.65M | 833.33k |
| Low Estimate | -- | -- | 4.7M | -- |
| High Estimate | -- | -- | 7.5M | 2.5M |
| Year Ago Sales | -- | -- | -- | 5.65M |
| Sales Growth (year/est) | -- | -- | 0.00% | -85.25% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | -0.01 | -0.01 |
| 7 Days Ago | 0 | 0 | -0.01 | -0.01 |
| 30 Days Ago | 0 | 0 | -0.01 | -0.01 |
| 60 Days Ago | 0 | 0 | -0.01 | -0.01 |
| 90 Days Ago | 0 | 0 | -0.01 | -0.01 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | 2 |
| Up Last 30 Days | -- | -- | 1 | 3 |
| Down Last 7 Days | -- | -- | 2 | -- |
| Down Last 30 Days | -- | -- | 2 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| SCLP.L | -- | -- | -77.79% | 9.35% |
| S&P 500 | 6.40% | 6.07% | 9.36% | 14.28% |
Related Tickers
TCF.L Theracryf Plc
0.2250
0.00%
ACUT AccuStem Sciences, Inc.
0.4509
-0.07%
SAR.L Sareum Holdings plc
17.50
0.00%
OXB.L Oxford Biomedica plc
279.00
+0.18%
IMM.L ImmuPharma plc
2.5700
+0.39%
TRX.L Tissue Regenix Group plc
37.50
-1.32%
POLB.L Poolbeg Pharma PLC
2.7000
0.00%
ABVX.PA ABIVAX Société Anonyme
4.9700
+3.54%
FUM.L Futura Medical plc
9.90
+1.02%
HNSA.ST Hansa Biopharma AB (publ)
21.88
-1.08%